|
Title
|
|
|
|
The therapeutic potential of RNA regulation in neurological disorders
|
|
|
Author
|
|
|
|
|
|
|
Abstract
|
|
|
|
| Introduction: Gene regulation is the term used to describe the mechanisms by which a cell increases or decreases the amount of a gene product (RNA or protein). In complex organs such as the brain, gene regulation is of the utmost importance; aberrations in the regulation of specific genes can lead to neurological disorders. Understanding these mechanisms can create new strategies for targeting these disorders and progress is being made. Two drugs that function at the RNA level (nusinersen and eteplirsen) have now been approved by the FDA for the treatment of Spinomuscular atrophy and Duchenne muscular dystrophy, respectively; several other compounds for neurological disease are currently being investigated in preclinical studies and clinical trials. Areas covered: We highlight how gene regulation at the level of RNA molecules can be used as a therapeutic strategy to treat neurological disorders. We provide examples of how such an approach is being studied or used and discuss the current hurdles. Expert opinion: Targeting gene expression at the RNA level is a promising strategy to treat genetic neurological disorders. Safe administration, long-term efficacy, and potential side effects, however, still need careful evaluation before RNA therapeutics can be applied on a larger scale. |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
Expert opinion on therapeutic targets. - London
|
|
|
Publication
|
|
|
|
Abingdon
:
Taylor & francis ltd
,
2018
|
|
|
ISSN
|
|
|
|
1472-8222
|
|
|
DOI
|
|
|
|
10.1080/14728222.2018.1542429
|
|
|
Volume/pages
|
|
|
|
22
:12
(2018)
, p. 1017-1028
|
|
|
ISI
|
|
|
|
000450628300006
|
|
|
Pubmed ID
|
|
|
|
30372655
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (open access)
|
|
|
|
|
|